May 4 (Reuters) - Johnson & Johnson JNJ.N recalled some of its products last week at the request of the U.S. Food and Drug Administration, the latest of several product recall in the past 18-months. [ID:nN04255618]
Below are details of those recalls.
April 30, 2010:
Products: 40 products including liquid infant and children’s pain relievers, Tylenol, and Motrin and allergy medications Zyrtec and Benadryl.
Problem: Manufacturing deficiencies that may have affected the quality, purity or potency of the medicines.
January 15, 2010:
Products: 53 million bottles of over-the-counter products including Tylenol, Motrin and Rolaids, Benadryl and St. Joseph’s Aspirin, involving lots in the Americas, the United Arab Emirates and Fiji.
Problem: Unusual moldy, musty or mildew-like odor
Product: Expands November recall of Tylenol Arthritis Pain Caplets
Problem: Consumer reports of unusual moldy odor with the 100-count bottles
Product: Five lots of Tylenol Arthritis Pain Caplets
Problem: Reports of an unusual musty or mildew-like odor that was associated with nausea, stomach pain, vomiting and diarrhea
Products: Some lots of infants’ and children’s Tylenol
Problem: Possible bacterial contamination
Product: About 12,000 bottles of Mylicon over-the-counter infant anti-gas drops in the dye-free variety. (Mylicon sells the product in a 50-50 joint venture with Merck & Co MRK.N)
Problem: Bottles may have contained metal fragments. (Compiled by Phil Wahba, editing by Leslie Gevirtz)
Our Standards: The Thomson Reuters Trust Principles.